Announcing the GatewayFDA Blog


Entering the U.S. market can be difficult—and when your product is regulated by the U.S. Food and Drug Administration, it can be downright intimidating.

Hodgson Russ is proud to announce the launch of GatewayFDA, a blog that provides analysis, commentary, and resources to help foreign pharmaceutical and medical device companies make sense of ever-evolving FDA regulations and understand the complete range of U.S. legal issues that may complicate bringing a drug, medical device, or other FDA-regulated product or service to market in the United States.

GatewayFDA is written by a team of attorneys experienced in successfully guiding FDA-regulated companies through regulatory, corporate, intellectual property, licensing, product liability, and other critical U.S. legal challenges.

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.